microcephaly

A vaccine to protect against the Zika virus produced an immune response in the first phase of a randomized clinical trial, researchers report in the Lancet. They are now testing the efficacy of the vaccine.

Scientists are still trying to gain a better understanding of the Zika virus–which the World Health Organization has called an international public health emergency–while public health officials scramble to manage outbreaks without a complete scientific picture of the disease.